Introduction {#s1}
============

Astrocytes are essential for brain homeostasis. They indeed support neurons both structurally and functionally by providing nutrients and neurotrophic factors, removing neurotransmitters and waste metabolites to ensure a homeostatic environment ([@B79]). Astrocytes regulate neurogenesis, axonal guidance, synaptogenesis ([@B4]), as well as blood--brain barrier (BBB) function. Although still controversial, astrocytes may also release gliotransmitters to modulate synaptic transmission ([@B8]; [@B41]). Last but not least, after brain injury, astrocytes are involved in neuroinflammatory responses in an attempt of repair and/or remodeling.

Astrocytes are highly secretory cells, with their secretome containing hundreds of molecules ([@B28]; [@B33]; [@B50]). Recent proteomic studies provided exciting insights into the contribution of astrocyte-derived signals in their pleiotropic functions in brain health and diseases ([@B53]). In this minireview, we will highlight recent findings on some molecules actively secreted by astrocytes and implicated in two specific functions, namely, regulation of neural stem cells (NSCs) and their progeny within adult neurogenic niches and modulation of BBB function. These apparently distant conditions are analyzed together as they share a strict dependence on astrocyte-secreted products.

Astrocytes as Key Modulators in Adult Neurogenic Niches {#s2}
=======================================================

The term adult neurogenesis (aNG) refers to the generation of new functionally integrated neurons in the adult brain. This peculiar form of neuroplasticity occurs in restricted areas of mammalian brain, the subventricular zone (SVZ) in the lateral ventricles and the subgranular zone (SGZ) in the hippocampal dentate gyrus (DG).

While the SVZ region is considered a poorly relevant neurogenic site in humans, neurogenesis occurring in the DG appears of physiological significance. Recently, the presence of thousands of adult-born neuroblasts (NBs) in the hippocampus of healthy people was described ([@B75]). In this region, neural stem/progenitor cells (NSC/NPC) self-renew and give rise to transiently amplifying progenitor cells which, in turn, can generate NBs capable of terminal neuronal differentiation. Post-mitotic neuronal progeny can be functionally integrated as granule cells into the adult hippocampal circuitry ([@B14]; [@B57]). In recent years, adult hippocampal neurogenesis (ahNG) has attracted growing interest due to its potential involvement in cognition and memory, mood, and emotional behavior ([@B2]; [@B34]; [@B3]; [@B17]). ahNG is profoundly dysregulated in several neuropsychiatric/neurodegenerative disorders opening to the possibility that it may participate in their pathophysiology or contribute to some associated symptoms, such as dementia and depressed mood ([@B47]; [@B18]; [@B107]). Very recently, it has been reported that postmortem tissue from AD patients contained remarkably fewer DG NBs suggesting their degeneration in the disease ([@B75]). This seminal paper confirmed previous key studies in the field ([@B89]; [@B13]).

An important functional and anatomical concept in aNG is the \"neurogenic niche,\" a permissive and instructive microenvironment which is crucial for preserving NSC functions, including their proliferative and differentiative properties ([@B45]). Although cell--cell contacts are relevant, paracrine signals originating from astrocytes within the niche appear very important. It was demonstrated that astrocytes are important neurogenic niche components which instruct NSC/NPC to adopt a neuronal fate ([@B88]). Hence, the interest in the identity of astrocyte-secreted niche signals has been growing ([@B23]). We will now highlight key findings showing how astrocytes modulate aNG through release of different classes of secretory substances, as summarized in [**Figure 1**](#f1){ref-type="fig"}.

![Role of astrocyte-derived molecules in the adult neurogenic niche. In the permissive and instructive microenvironment of the neurogenic niche, astrocytes profoundly modulate adult neurogenesis through soluble signals. Neural stem/progenitor cells (NSC/NPC) self-renewal, neuronal commitment/differentiation, migration of neuroblasts, as well as survival and functional integration of newly born neurons can be affected by different classes of astrocytic-derived factors such as morphogens (i.e., Wnt3 and Wnt7), gliotransmitters (i.e., D-serine and glutamate), extracellular matrix (ECM) proteins \[i.e., thrombospondin 1 (TSP-1)\], and cytokines/chemokines/acute phase proteins \[i.e., IL-1β, IL-6, and lipocalin-2 (LCN-2)\].](fphar-10-01346-g001){#f1}

Morphogens {#s2_1}
----------

Among the first candidate molecules identified for their role in aNG were morphogenic factors of the Wnt protein family. Several members, including Wnt3 and Wnt7, are expressed by hippocampal astrocytes together with Wnt receptors and Wnt/β-catenin signaling pathway components ([@B59]). Hippocampal niche astrocytes actively induce ahNG through secretion of Wnt proteins and activation of Wnt downstream signaling pathways. Overexpression of Wnt3 enhances neuronal differentiation, while blockade of Wnt signaling strongly reduces ahNG *in vivo* and *in vitro* ([@B59]). Moreno-Estelles demonstrated that Wnt7a released by astrocytes in the adult neurogenic niche is a key factor promoting NSC self-renewal ([@B74]).

Gliotransmitters {#s2_2}
----------------

D-serine and Glutamate (Glu) were identified as molecules by which niche astrocytes regulate maturation, survival, and functional integration into local synaptic networks of adult-born neurons. To investigate the role of astrocytic exocytosis on aNG, SNAP Receptor protein (SNARE)-dependent exocytosis was genetically impaired in niche astrocytes ([@B93]). Inhibition of vesicular release resulted in severely impaired integration and survival of newly generated hippocampal neurons, whereas developmentally born neurons appeared unaffected ([@B93]). Adult-born neurons located within the territories of exocytosis-deficient astrocytes displayed reduced dendritic spine density and glutamatergic synaptic input, which correlated with decreased D-serine. Chronic administration of D-serine partially rescued defective phenotypes and restored N-methyl-D-aspartate (NMDA)-mediated synaptic transmission and dendritic maturation in mice with impaired astrocytic vesicular release ([@B93]). The observation that rescue was only partial suggested that other molecules released by astrocytes could be important for maturation of adult-born hippocampal neurons. A critical role of vesicular Glu release from astrocytes was previously demonstrated in the SVZ where newly generated NBs migrate a long distance to reach their final destination, the olfactory bulb (OB). Platel et al. demonstrated that migrating NBs, which acquire functional NMDA receptor activity on their way to the OB, are ensheathed by astrocytes releasing glutamate in a Ca^2+^-dependent manner ([@B81]). They showed that: i) increasing calcium in astrocytes induced NMDA receptor activity in NB; ii) blocking vesicular astrocytic release eliminated spontaneous NMDA receptor activity in NB; and iii) deletion of functional NMDA receptors in adult-born NB decreased generation and survival of newborn neurons in adult OB ([@B81]). Altogether, these findings correlate astrocyte-released Glu with generation, survival, and functional integration into local synaptic networks of adult-born OB neurons.

Extracellular Matrix (ECM) Proteins {#s2_3}
-----------------------------------

Several astrocyte-secreted ECM proteins modulate cellular functions. Usually these proteins are expressed at high levels during development and at lower levels in adulthood. Upon brain injury, their expression is upregulated, especially in reactive astrocytes, and they are often associated with CNS remodeling and synaptogenesis. Some ECM proteins play also an important role in the neurogenic microenvironment. The most investigated astrocyte-secreted matricellular proteins are thrombospondins (TSPs) which mediate cell--cell and cell--matrix interaction by binding other ECM components, membrane receptors, growth factors, and cytokines. TSP-1 represents a key astrocyte-derived pro-neurogenic factor which promotes neuronal differentiation of NSC ([@B61]). Adult TSP-1^−/−^ mice exhibit reduced NSC proliferation and neuronal differentiation in both SVZ and SGZ ([@B61]). The voltage-gated calcium channel α2δ1 subunit was proposed to be a receptor which mediates TSP-1 synaptogenic effects ([@B36]). The α2δ1 subunit was also proven to be functionally expressed by adult hippocampal NPC and to mediate TSP-1 and pregabalin (an anticonvulsant/analgesic α2δ1 ligand) pro-neurogenic effects both *in vitro* and *in vivo* ([@B99]). These findings were further extended in recent studies proposing a key role for nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling whose activation occurs in adult NSC *via* membrane receptors, including neurotransmitter receptors and α2δ1 ([@B66]; [@B20]; [@B16]). NF-κB p50^−/−^ mice exhibit strongly reduced ahNG *in vivo* ([@B32]) and *in vitro* ([@B65]; [@B98]; [@B15]). Interestingly, TSP-1 promotes an increase in the percentage of newly formed neurons in wild type, but not in p50^−/−^-derived ahNPC which have reduced α2δ1 expression levels ([@B30]). Altogether, these data suggested that a disturbed astrocyte--NSC communication *via* TSP-1 may contribute to defects in ahNG in absence of p50.

Cytokines and Acute Phase Proteins {#s2_4}
----------------------------------

In contrast with the notion that inflammatory cytokines inhibit neuronal differentiation ([@B100]; [@B73]), IL-1β and IL-6, both highly expressed in neurogenic niches astrocytes, strongly promote NSC neuronal differentiation ([@B11]). Lipocalin-2 (LCN-2) is an acute phase protein produced by and acting on astrocytes ([@B54]) which serves as \"help-me\" signal to activate astrocytes and microglia ([@B104]). Although its modulatory role in the CNS is not completely understood LCN-2 is commonly regarded as a deleterious signal ([@B39]) and a key target in regulating astrocyte reactivity. Indeed it has been demonstrated that knockdown of LCN-2 leads to reduced protein secretion from reactive astroglial cells, counteracting the perpetuation of inflammation in nearby astrocytes ([@B87]). LCN-2 is encoded by a NF-κB target gene ([@B97]), and its expression is increased in the secretome of p50^−/−^ astrocytes ([@B30]; [@B19]). Initially, based on these findings and its deleterious effects, our group hypothesized that overexpressed LCN-2 may contribute to impaired ahNG in p50^−/−^ mice. To our surprise, LCN-2 promoted, in a concentration-dependent manner, neuronal differentiation of ahNPC. Under the same experimental conditions, LCN-2 had little effect on neuronal differentiation of p50^−/−^ ahNPC which exhibited downregulation of the LCN-2 receptor 24p3R ([@B30]). Altogether, these novel data proposed LCN-2 as a novel and unexpected astroglial-derived signal able to promote neuronal fate specification of ahNPC ([@B19]). Recently, these findings were further extended by the demonstration that LCN-2^−/−^ mice display deficits in proliferation and neuronal commitment of NSC and, in parallel, hippocampal dysfunction ([@B40]).

In summary, at present several astrocyte-derived signals which act as positive modulators of NSC and their progeny have been identified and characterized. Of note, little is currently known on soluble molecules of astrocytic origin which may exert negative effects on aNG. Anatomical and functional segregation along the hippocampal dorso-ventral axis is a well-established concept ([@B48]; [@B95]), and marked differences in neurogenesis rate have been described in the dorsal compared to the ventral dentate gyrus ([@B80]). It would be interesting to investigate whether subregional specificities in ahNG may also rely, at least in part, on different astrocyte-secreted molecules.

The Dual Role of Astrocytic-Derived Factors: From Endothelial Protection to Disruption of Bbb Function {#s3}
======================================================================================================

The BBB is constituted by specialized endothelial cells, supported in their functions by astrocytes and pericytes, and is part of a more complex network, the neurovascular unit (NVU), that includes also microglia, neurons, and mast cells. Brain microvascular endothelial cells, the main anatomical BBB elements, express tight junctions (TJs) and adherens junctions (AJs) ([@B52]; [@B31]), that allow a selective para- and transcellular movement of molecules and solutes across the barrier ([@B43]; [@B42]). Trafficking through the BBB is regulated by specific transporters ([@B56]), as well as by efflux pumps such as P-glycoprotein (P-gp) ([@B12]). The BBB contributes to make CNS a site of immune privilege, as low expression of adhesion molecules and tightness of cell-to-cell connections limit the access of pathogens and immune cells, preserving immune surveillance ([@B35]).

Astrocytes appear fundamental in BBB function. *In vitro*, barrier properties are lost in the absence of astrocytes ([@B44]) and reestablished by astrocyte conditioned media or when astrocyte--endothelial cells contact is provided ([@B96]; [@B76]; [@B51]; [@B29]). Further, endothelial cells derived from non-CNS districts, cultured in the presence of astrocytes or astrocyte-secreted factors, acquire BBB specific features, including expression of TJ or P-gp ([@B82]; [@B1]).

Pericytes and radial glia, the major source of astrocyte precursors ([@B64]), are essential in an early stage of barrier induction, whereas astrocytes play a major role later on, favoring barrier maturation and maintenance ([@B77]; [@B78]).

In pathological conditions, morphological changes in reactive astrocytes may induce loss of their interaction with endothelial cells ([@B6]). Depending on insult type, astrocytes undergo loss-of-function \[e.g., failure of glutamate uptake ([@B22])\] and/or gain-of-function \[production of a wide range of molecules including cytokines ([@B46]; [@B21])\]. All these events can lead to reduction or exacerbation of BBB damage. Herein we will analyze the crosstalk between astrocytes and endothelial cells in BBB function, focusing on few astrocytic soluble mediators that belong to the classes discussed above ([**Figure 2**](#f2){ref-type="fig"}).

![The dual role of astrocytic-derived factors on blood--brain barrier (BBB). Under physiological conditions, astrocytes release morphogens \[sonic hedgehog (Shh) and retinoic acid (RA)\], trophic factors (VEGF), and gliotransmitters (Glu) that, reinforcing both the formation of new vessels and the tightness of their junctions, improve the proper endothelial function at the BBB. After inflammatory stimuli, secretion of morphogens (Shh and RA) is reactivated in an attempt to reduce the inflammatory-mediated damage on endothelial layer. On the contrary, VEGF and Glu induce junctional damage and BBB leakiness, as well as increased expression of efflux pumps \[P-glycoprotein (P-gp)\]. The secretion of cytokines and chemokines is further increased, thus facilitating BBB leakage and leukocyte migration.](fphar-10-01346-g002){#f2}

Morphogens {#s3_1}
----------

Sonic hedgehog (Shh) is one of the main mediators of BBB induction. It is expressed in astrocytes, and its receptor has been detected *in vivo* in mice and human blood vessels as well as in cultured BBB endothelial cells ([@B5]). Its genetic deletion results in reduced expression of endothelial junctional proteins and accumulation of solutes in CNS ([@B5]). Shh is overexpressed in astrocytes following an ischemic insult and reinforces junctional tightness ([@B60]) thus reducing BBB leakage and brain edema ([@B103]). Accordingly, Shh mimetics promote immune-quiescence dampening leukocyte extravasation into the CNS, through the downregulation of adhesion molecules, as observed both *in vitro* ([@B5]) and *in vivo* ([@B86]). Retinoic acid (RA) is produced by radial glia and behaves as a morphogen playing a main role during brain development ([@B49]; [@B70]). It is enhanced in reactive astrocytes after middle cerebral artery occlusion ([@B58]) and contributes to ameliorate barrier properties. RA indeed reinforces the expression of junctional proteins and P-gp in endothelial cells ([@B70]) and reduces inflammatory genes (IL-6, CCL2, and VCAM-1) ([@B69]). It also modifies ICAM-1 glycan composition ([@B27]), affecting the interaction of endothelial cells with PBMCs, an event that is modulated by astrocytes ([@B90]). Thus, beyond their physiological function in barrierogenesis, both Shh and RA play a role in the delay of BBB breakdown under pathological conditions.

Trophic Factors {#s3_2}
---------------

The main vascular trophic factor is VEGF-A. In contrast to its main activity in promoting angiogenesis, proliferation, differentiation, and survival of endothelial cells during brain development ([@B37]; [@B110]), in adulthood VEGF is a potent inducer of BBB disruption. Reactive astrocytes are VEGF-A primary source and increased BBB immunoreactivity is often observed in animal models of multiple sclerosis ([@B62]; [@B9]), Alzheimer\'s disease ([@B108]), ischemia, and traumatic brain injury ([@B85]; [@B55]; [@B102]). Acting either directly on its receptors on endothelial cells, ([@B9]; [@B26]), or indirectly, through the modulation of matrix metalloproteinases (MMPs) ([@B68]; [@B91]), VEGF-A induces changes in the tightness of endothelial junctions, causing brain edema, as well as leukocyte adhesion and infiltration in the CNS. Accordingly, blockade of VEGF-A through specific antibodies alleviates BBB disruption ([@B67]), whereas VEGF-A knockdown in astrocytes results in reduced endothelial expression of MMP9 and prevention of barrier leakage ([@B91]).

Cytokines and Chemokines {#s3_3}
------------------------

Cytokines released by reactive astrocytes in close proximity to the BBB induce TJ re-organization \[TNF and IFNγ ([@B24]), CCL2 ([@B106])\], and immune cells recruitment \[CXCL10, CCL2, CCL5, IL-8, CXCL12 ([@B21])\], further contributing to neuroinflammation. By stimulating proteosomal degradation of junctional proteins ([@B25]), astrocyte-derived IL-6 increases barrier permeability and the release of chemokines, thus enhancing PBMCs\' access into the CNS ([@B94]). Astrocytes may also mediate endothelial responses to cytokines. Their presence is in fact necessary for INFγ to affect barrier properties, whereas only slight effects are reported on endothelial cells cultured alone ([@B24]). Conversely, astrocytes counteracted increased barrier permeability induced by TNF alone, or in association with IL-6, on induced plutipotent stem cells-derived endothelial cells. The modulation of BBB properties by astrocyte-derived factors appears to be the result of a complex balance. Indeed, stressed astrocytes release not only factors triggering barrier breakdown (i.e., IFNγ, IL-1β, CCL5, CCL2, and CCL4), but anti-inflammatory ones like IL-4 ([@B63]).

In addition, among astrocyte-derived factors, granulocyte and macrophage colony-stimulating factor (GM-CSF) exhibits a dual and controversial role. While promoting TJ internalization and downregulation ([@B84]; [@B109]) and monocyte migration through the BBB ([@B101]), GM-CSF also protects endothelial cells from apoptosis ([@B92]), induces claudin-5 overexpression ([@B84]), and stimulates angiopoietin-1 release from pericytes, thereby reducing barrier permeability ([@B105]).

Gliotransmitters {#s3_4}
----------------

Glu modifies BBB function through interaction with endothelial NMDA and metabotropic glutamate receptors. Activated astrocytes release large amounts of glutamate that act on endothelial NMDA receptors and promote oxidative stress ([@B83]), TJ disruption, and increased BBB permeability ([@B7]). Further, glutamate increases the expression of P-gp, as reported in endothelial cells cultured with astrocytes derived from amyotrophic lateral sclerosis (ALS) patients ([@B72]). This condition can justify \"P-gp--mediated pharmacoresistance\" ([@B71]), often observed in diseases including ALS and epilepsy ([@B10]; [@B38]).

Concluding Remarks {#s4}
==================

Our current understanding of the role of astrocytes in adult mammalian brain is growing exponentially, unraveling a remarkable variety of functions under the control of these cells both under physiological and pathological conditions. In recent years, the fact that astrocytes execute many of their crucial functions in a paracrine manner is also providing fuel to major advancements in astrocyte biology. Several proteins identified in studies that have applied proteomics for comprehensive profiling of astrocyte-secreted proteins confirmed that many of them correlate with well-known astrocyte-mediated cell-to-cell communication pathways. In some cases, soluble signals released by astrocytes *in vitro* created the opportunity to propose novel unexpected roles for these molecules and astrocytes. Hopefully, in the future, deeper analysis of the astrocyte secretome may further increase our current knowledge on the full potential of these cells and their secreted molecules not only as active participants in pathophysiological events, but as pharmacological targets or even as therapeutics for CNS diseases.
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